Rixubis 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued2 / 
affected3  
amended 
on 
N/0045 
Minor change in labelling or package leaflet not 
22/09/2022 
PL 
connected with the SPC (Art. 61.3 Notification) 
II/0044 
B.II.e.1.a.3 - Change in immediate packaging of the 
21/07/2022 
SmPC 
finished product - Qualitative and quantitative 
composition - Sterile medicinal products and 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
biological/immunological medicinal products 
IA/0043/G 
This was an application for a group of variations. 
07/02/2022 
Annex II 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
Page 2/12 
 
 
 
 
 
 
 
 
 
manufacturer of a novel excipient 
II/0041/G 
This was an application for a group of variations. 
28/10/2021 
n/a 
B.II.d.2.c - Change in test procedure for the finished 
product - Substantial change to or replacement of a 
biol/immunol/immunochemical test method or a 
method using a biol. reagent or replacement of a 
biol. reference preparation not covered by an 
approved protocol 
B.I.b.2.d - Change in test procedure for AS or 
starting material/reagent/intermediate - Substantial 
change to or replacement of a 
biological/immunological/immunochemical test 
method or a method using a biological reagent for a 
biological AS 
IA/0042/G 
This was an application for a group of variations. 
15/10/2021 
n/a 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
IB/0040 
B.II.b.1.z - Replacement or addition of a 
30/06/2021 
n/a 
manufacturing site for the FP - Other variation 
Page 3/12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II/0035/G 
This was an application for a group of variations. 
11/03/2021 
n/a 
B.I.b.1.f - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Change outside the 
approved specifications limits range for the AS 
B.I.b.2.d - Change in test procedure for AS or 
starting material/reagent/intermediate - Substantial 
change to or replacement of a 
biological/immunological/immunochemical test 
method or a method using a biological reagent for a 
biological AS 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
14/01/2021 
n/a 
PRAC Recommendation - maintenance 
/202006 
nonacog gamma 
IB/0039 
B.I.b.2.e - Change in test procedure for AS or 
04/12/2020 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
IA/0038/G 
This was an application for a group of variations. 
24/09/2020 
n/a 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
Page 4/12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.b.1.d - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
B.I.b.1.d - Change in the specification parameters 
Page 5/12 
 
 
 
 
 
and/or limits of an AS, starting 
material/intermediate/reagent - Deletion of a non-
significant specification parameter (e.g. deletion of 
an obsolete parameter) 
IA/0036 
B.II.e.7.b - Change in supplier of packaging 
02/09/2020 
n/a 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
IB/0034/G 
This was an application for a group of variations. 
15/05/2020 
n/a 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where 
batch control/testing takes place 
B.I.a.1.k - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - New 
storage site of MCB and/or WCB 
B.I.a.1.k - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - New 
storage site of MCB and/or WCB 
B.I.a.1.k - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - New 
storage site of MCB and/or WCB 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
16/01/2020 
n/a 
PRAC Recommendation - maintenance 
/201906 
nonacog gamma 
IA/0033 
A.7 - Administrative change - Deletion of 
09/01/2020 
18/12/2020 
Annex II and 
manufacturing sites 
PL 
Page 6/12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R/0029 
Renewal of the marketing authorisation. 
19/09/2019 
14/11/2019 
SmPC, Annex 
II and Labelling 
IB/0032 
B.I.d.1.a.4 - Stability of AS - Change in the re-test 
16/10/2019 
n/a 
period/storage period - Extension or introduction of a 
re-test period/storage period supported by real time 
data 
IA/0030 
B.II.e.7.b - Change in supplier of packaging 
30/04/2019 
n/a 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
II/0028 
B.II.c.1.d - Change in the specification parameters 
14/03/2019 
n/a 
and/or limits of an excipient - Change outside the 
approved specifications limits range 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
17/01/2019 
n/a 
PRAC Recommendation - maintenance 
/201806 
nonacog gamma 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
12/07/2018 
n/a 
PRAC Recommendation - maintenance 
/201712 
nonacog gamma 
IB/0026 
B.II.b.2.a - Change to importer, batch release 
30/05/2018 
n/a 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
IA/0025/G 
This was an application for a group of variations. 
27/04/2018 
n/a 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
Page 7/12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
A.7 - Administrative change - Deletion of 
manufacturing sites 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
11/01/2018 
n/a 
PRAC Recommendation - maintenance 
/201706 
nonacog gamma 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
06/07/2017 
n/a 
PRAC Recommendation - maintenance 
/201612 
nonacog gamma 
IB/0021 
B.I.b.2.e - Change in test procedure for AS or 
04/07/2017 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
N/0022 
Minor change in labelling or package leaflet not 
13/06/2017 
14/11/2019 
Labelling and 
connected with the SPC (Art. 61.3 Notification) 
PL 
IB/0020 
B.I.b.2.a - Change in test procedure for AS or 
26/04/2017 
n/a 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
12/01/2017 
n/a 
PRAC Recommendation - maintenance 
/201606 
nonacog gamma 
IB/0017 
B.I.e.5.c - Implementation of changes foreseen in an 
13/10/2016 
n/a 
approved change management protocol - For a 
biological/immunological medicinal product 
Page 8/12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
07/07/2016 
n/a 
PRAC Recommendation - maintenance 
/201512 
nonacog gamma 
IB/0016/G 
This was an application for a group of variations. 
05/07/2016 
n/a 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
variation 
IA/0015 
B.II.c.3.a.1 - Change in source of an excipient or 
02/05/2016 
n/a 
reagent with TSE risk - From TSE risk material to 
vegetable or synthetic origin - For excipients or 
reagents NOT used in the manufacture of a 
biol/immunol AS or in a biol/immunol medicinal 
product 
IB/0013/G 
This was an application for a group of variations. 
31/03/2016 
26/05/2016 
SmPC, 
B.II.f.1.b.5 - Stability of FP - Extension of the shelf 
life of the finished product - Biological/immunological 
medicinal product in accordance with an approved 
stability protocol 
B.II.f.1.d - Stability of FP - Change in storage 
conditions of the finished product or the 
diluted/reconstituted product 
Labelling and 
PL 
Page 9/12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.II.f.1.d - Stability of FP - Change in storage 
conditions of the finished product or the 
diluted/reconstituted product 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
14/01/2016 
n/a 
PRAC Recommendation - maintenance 
/201506 
nonacog gamma 
IA/0012/G 
This was an application for a group of variations. 
08/12/2015 
n/a 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
B.I.b.1.b - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Tightening of 
specification limits 
II/0010 
C.I.4 - Change(s) in the SPC, Labelling or PL due to 
05/11/2015 
26/05/2016 
SmPC, Annex 
new quality, preclinical, clinical or pharmacovigilance 
II and PL 
data 
II/0008 
B.I.e.2 - Introduction of a post approval change 
05/11/2015 
n/a 
management protocol related to the AS 
PSUSA/10320
Periodic Safety Update EU Single assessment - 
10/09/2015 
n/a 
PRAC Recommendation - maintenance 
/201412 
nonacog gamma 
Page 10/12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IB/0009 
B.I.b.2.e - Change in test procedure for AS or 
24/08/2015 
n/a 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
IAIN/0007 
B.II.b.2.c.1 - Change to importer, batch release 
02/06/2015 
26/05/2016 
Annex II and 
arrangements and quality control testing of the FP - 
PL 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
IAIN/0006/G 
This was an application for a group of variations. 
02/06/2015 
26/05/2016 
SmPC, Annex 
II, Labelling 
and PL 
A.1 - Administrative change - Change in the name 
and/or address of the MAH 
A.5.a - Administrative change - Change in the name 
and/or address of a manufacturer/importer 
responsible for batch release 
C.I.8.a - Introduction of or changes to a summary of 
Pharmacovigilance system - Changes in QPPV 
(including contact details) and/or changes in the 
PSMF location 
IB/0003 
B.I.b.2.a - Change in test procedure for AS or 
29/05/2015 
n/a 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IB/0005 
B.I.d.1.a.4 - Stability of AS - Change in the re-test 
22/05/2015 
n/a 
period/storage period - Extension or introduction of a 
Page 11/12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
re-test period/storage period supported by real time 
data 
N/0002 
Minor change in labelling or package leaflet not 
13/03/2015 
26/05/2016 
PL 
connected with the SPC (Art. 61.3 Notification) 
IB/0001 
B.I.b.2.a - Change in test procedure for AS or 
02/03/2015 
n/a 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
Page 12/12 
 
 
 
 
 
 
 
 
 
 
 
 
